News Releases

Checkpoint Surgical today announced the transition of Len Cosentino from President and CEO to the role of Founder and Executive Advisor. Additionally, several other organizational changes to support the company’s rapid growth have recently been made. Checkpoint Surgical makes surgical devices for intraoperative nerve care.

Checkpoint Surgical announced today the launch of the Checkpoint Edge™ Nerve Cutting Kit, extending the breadth of the company’s intraoperative nerve care portfolio. The Checkpoint Edge Nerve Cutting Kit is the first offering in Checkpoint Surgical’s planned portfolio of nerve-specific instruments, with further expansion planned in the coming months.

Checkpoint Surgical, Inc., the leader in intraoperative nerve repair stimulation technology, today announced it has enrolled the first patient in its multi-center clinical study of the company’s breakthrough nerve regeneration technology. The patient was enrolled at The Ohio State University, one of four sites actively enrolling patients in the double-blind, randomized clinical trial. Other participating sites include the Medical College of Wisconsin, Northwestern University, and Walter Reed National Military Medical Center. The study is also funded by a Department of Defense Clinical Trial Award to Dr. Amy Moore at The Ohio State University.

Checkpoint Surgical announces the full commercial release of the Checkpoint Guardian Nerve Stimulator, along with FDA clearance and market launch of the new Checkpoint Guardian Intraoperative Lead Accessory, at the 2021 ASSH. The new Checkpoint Guardian provides more precise controls and information to take nerve assessment to the next level. The Intraoperative Lead Accessory extends the surgeon’s ability to consistently and precisely assess nerve health by allowing safe, reliable same-site stimulation. In combination, the two devices provide a powerful surgical tool for intraoperative nerve assessment.

Checkpoint Surgical, Inc., a privately held US-based medical device company with proprietary neurostimulation technology for nerve protection and repair, announced today the completion of a $16 million capital raise led by River Cities Capital, a Cincinnati-based healthcare-focused growth equity firm. Existing backers also participated in the round, including Cleveland-based venture funds Mutual Capital Partners and JumpStart NEXT Fund, First Analysis, a growth equity firm based in Chicago, and several other investors.

Checkpoint Surgical, Inc. has announced an expansion of their intraoperative nerve care product line with the introduction of the NeuroShield® Chitosan Nerve Wrap. The NeuroShield Wrap marks Checkpoint’s first product in a planned line of chitosan-based biological implants to support nerve healing.

Checkpoint Surgical today unveiled a new corporate logo as the first step in its campaign to better identify the brand with its nerve care mission. The new mark is designed to better represent Checkpoint Surgical’s focused mission to advance the science and practice of nerve protection and repair to improve the quality of life for patients and physicians...

Checkpoint Surgical recently was named by Crain's Cleveland Business as one of the 2020 Best Employers in Ohio. The statewide survey and awards program is designed to identify, recognize and honor the best places of employment in Ohio, benefiting the state's economy, its workforce and businesses...

Checkpoint Surgical has announced that it will add 18 new jobs at its headquarters in Highland Hills, Ohio, with the assistance of an Ohio Job Creation Tax Credit totaling $200,000. The new jobs added will be in such areas as engineering, technical support, sales and marketing...

A surgical procedure known as Targeted Muscle Reinnervation (TMR) provides amputees with new hope for relief from pain. According to the Amputee Coalition, up to 85% of the two million amputees living in the United States suffer from chronic pain, commonly referred to as phantom limb pain or residual limb pain...

Checkpoint Surgical announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for the Checkpoint brief electrostimulation therapy (BEST) system. The Checkpoint BEST system is designed to provide electrical stimulation of peripheral nerves to promote nerve regeneration...

In response to demand by European surgeons for the Checkpoint® Nerve Stimulator/Locator, an exclusive collaboration has been signed to facilitate easy access to Checkpoint products for European surgeons. Checkpoint is now available for direct purchase by customers at the Netherlands based company 2MEDICAL-europe BV, with a focus area including Germany, UK, Netherlands and Belgium...

Checkpoint Surgical, Inc., a U.S. based medical device company with proprietary neurostimulation technology for nerve protection and repair, announced the publication of the first peer-reviewed study comparing the use of its Checkpoint Nerve Stimulator/Locator to Medtronic’s Nerve Integrity Monitor for neural monitoring during thyroid and parathyroid surgeries in the April, 2019 edition of The Laryngoscope...

Checkpoint Surgical, Inc., a privately held U.S. based medical device company with proprietary neurostimulation technology for nerve protection and repair, announced today the completion of an $8.8 million preferred series capital raise led by Mutual Capital Partners, a Cleveland based venture fund investing in rapidly growing, post-revenue technology businesses...

Cleveland based Checkpoint Surgical’s flagship product, the Checkpoint Stimulator/Locator has been awarded the Inside Business Magazine 2013 Manny Award for New Product Development. Checkpoint’s revolutionary and groundbreaking handheld design has won almost universal acclaim in the surgical community for its ease of use and clinical accuracy in both identifying and threshold testing motor nerves inter-operatively...